In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
The price of 10x Genomics Inc (NASDAQ: TXG) closed at $13.68 in the last session, up 4.59% from day before closing price of $13.08. In other words, the price has increased by $4.59 from its previous closing price. On the day, 3.04 million shares were traded. TXG stock price reached its highest trading level at $13.705 during the session, while it also had its lowest trading level at $12.81.
Ratios:
We take a closer look at TXG’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.00 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 37.65. For the most recent quarter (mrq), Quick Ratio is recorded 4.68 and its Current Ratio is at 5.37. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.10.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Leerink Partners on February 13, 2025, Downgraded its rating to Market Perform and sets its target price to $12 from $25 previously.
On September 03, 2024, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $35.
Jefferies Upgraded its Hold to Buy on July 22, 2024, while the target price for the stock was maintained at $24.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 22 ’25 when Saxonov Serge sold 9,343 shares for $8.30 per share. The transaction valued at 77,540 led to the insider holds 1,083,625 shares of the business.
Hindson Benjamin J. sold 7,485 shares of TXG for $62,120 on May 22 ’25. The insider now owns 448,374 shares after completing the transaction at $8.30 per share. On May 22 ’25, another insider, Taich Adam, who serves as the Chief Financial Officer of the company, sold 4,044 shares for $8.30 each. As a result, the insider received 33,562 and left with 331,588 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TXG now has a Market Capitalization of 1684473216 and an Enterprise Value of 1337638656. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.73 while its Price-to-Book (P/B) ratio in mrq is 2.38. Its current Enterprise Value per Revenue stands at 2.141 whereas that against EBITDA is -9.107.
Stock Price History:
The Beta on a monthly basis for TXG is 1.99, which has changed by -0.27503973 over the last 52 weeks, in comparison to a change of 0.20799685 over the same period for the S&P500. Over the past 52 weeks, TXG has reached a high of $24.76, while it has fallen to a 52-week low of $6.78. The 50-Day Moving Average of the stock is 19.22%, while the 200-Day Moving Average is calculated to be 11.60%.
Shares Statistics:
According to the various share statistics, TXG traded on average about 3.83M shares per day over the past 3-months and 3379020 shares per day over the past 10 days. A total of 109.08M shares are outstanding, with a floating share count of 105.77M. Insiders hold about 15.28% of the company’s shares, while institutions hold 92.54% stake in the company. Shares short for TXG as of 1752537600 were 14263062 with a Short Ratio of 3.72, compared to 1749772800 on 13434164. Therefore, it implies a Short% of Shares Outstanding of 14263062 and a Short% of Float of 19.209999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
